ComplianceOnline

Auditing vs. monitoring, defining the purpose, application and process

Instructor: Arash Amirpour
Product ID: 701707
  • Duration: 60 Min

recorded version

$249.00
1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section
Last Recorded Date: Aug-2010

Training CD

$450.00
One CD is for usage in one location only.
(For multiple locations contact Customer Care)
CD and Ref. material will be shipped within 15 business days

Customer Care

Fax: +1-650-565-8542

Email: customercare@complianceonline.com

Read Frequently Asked Questions

In this Clinical Trial audit training learn risk-based approach to the process of monitoring and auditing clinical trial.

Why Should You Attend:
When conducting a clinical trial, the regulatory bodies expect from the sponsor to be in control of the quality of the trial. More specifically the sponsor should monitor (QC) and audit (QA) the trial in order to address this expectation. In addition, monitoring and auditing the trial provides the sponsor with information and insight that perfectly serves the purpose of protecting, as well as improving, the sponsor’s business interests by helping sponsor preventing legal, ethical or financial issues, related to possible error or trial misconduct, proactively from happening.

While monitoring, as a Quality Control activity, is the line’s responsibility, auditing should be performed by an independent Quality Assurance function that reports to the sponsor’s management.
Designing the monitoring and auditing program of a trial is depending on numerous factors such as :The Indication, Trial Phase, No of countries, recruiting sites, screened/enrolled subjects, Sponsor’s experience, Recruitment rate, Trial complexity, Amount of data generated pr. enrolled subject, Number and type of vendors involved etc. In addition, each trial setup introduces specific factors that should be identified and taken into account, during the planning phase.

With a risk-based approach this webinar will guide the attendees through an overview of all the processes of monitoring and auditing from the planning phase to the conduct, documentation, and finally, the application of the information obtained from these activities.

Areas Covered in the Seminar:
  • Background and Definitions.
  • Roles and Responsibilities.
  • Symbiosis of Monitoring & Auditing.
  • Planning & Conduct of Monitoring & Auditing.
  • Identifying & Handling Possible Fraud And Misconduct.
  • Ensuring A successful Trial Conduct.
  • Continuous Improvement.
  • Past Lessons vs. Future Trials.

Who Will Benefit:

This webinar will provide valuable assistance to all personnel in: Pharmaceutical, Biotechnology, Ros and Research Facilities Conducting Clinical Trials including:
  • Corporate Management
  • Managers in Clinical Development and Project Leaders
  • Quality Assurance Managers and Auditors
  • Monitors (CRAs)
  • Clinical Operations Staff
  • Regulatory Compliance Staff

Instructor Profile:
Arash Amirpour, Graduated in 1999 with Master Degree in Natural Sciences from the Technical University of Denmark.Ever since graduation, his professional work has been dedicated to the pharmaceutical industry. He has obtained experience in the manufacturing area and GMP regulation, while working as an Analytical Chemist in Novo Nordisk and as an QA-Engineer in a subsidiary of Ferring Pharmaceuticals.

In January 2003, he shifted to the area of clinical development and pharmacovigilance by joining International Clinical Quality Assurance department in Nycomed. He left Nycomed as a Senior Auditor to start his position as the Director in CliniQAl Consult Corp, at the end of 2007.

Mr. Amirpour is a certified ISO-9001:2000 Lead Auditor and a very active member of the Pharmaceutical industry. He is multilingual and has experience from several cultural backgrounds. He takes the human relations as an important and at times overseen factor of the absolute success in any pharmaceutical collaboration.

Follow us :
eCTD Submissions of IND and NDA/BLA to the US FDA, EU and Canada
Computer System Validation - Reduce Costs and Avoid 483s

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email customercare@complianceonline.com call +1-888-717-2436 (Toll Free).

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed
    Loading